Loading...
Loading...
Loading...
Loading...
Try browsing our complete catalog of products.
No reviews have been added for this product.
Atlas Antibodies
Atlas Antibodies


| Product Specifications | |
| Application | IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | HTAVISPQDPTLLIGSSLLATCSVHGDPPGATAEGLYWTLNGRRLPPELSRVLNASTLALALANLNGSRQRSGDNLVCHARDGSILAGSCLYVGLP |
| Gene Sequence | HTAVISPQDPTLLIGSSLLATCSVHGDPPGATAEGLYWTLNGRRLPPELSRVLNASTLALALANLNGSRQRSGDNLVCHARDGSILAGSCLYVGLP |
| Gene ID - Mouse | ENSMUSG00000007888 |
| Gene ID - Rat | ENSRNOG00000020030 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CRLF1 pAb (ATL-HPA041493) | |
| Datasheet | Anti CRLF1 pAb (ATL-HPA041493) Datasheet (External Link) |
| Vendor Page | Anti CRLF1 pAb (ATL-HPA041493) at Atlas Antibodies |
| Documents & Links for Anti CRLF1 pAb (ATL-HPA041493) | |
| Datasheet | Anti CRLF1 pAb (ATL-HPA041493) Datasheet (External Link) |
| Vendor Page | Anti CRLF1 pAb (ATL-HPA041493) |
| Citations for Anti CRLF1 pAb (ATL-HPA041493) – 1 Found |
| Yu, Shi-Tong; Zhong, Qian; Chen, Ren-Hui; Han, Ping; Li, Shi-Bing; Zhang, Hua; Yuan, Li; Xia, Tian-Liang; Zeng, Mu-Sheng; Huang, Xiao-Ming. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways. Cell Death & Disease. 2018;9(3):371. PubMed |


| Product Specifications | |
| Application | IHC |
| Reactivity | Human |
| Clonality | Polyclonal |
| Host | Rabbit |
| Immunogen | HTAVISPQDPTLLIGSSLLATCSVHGDPPGATAEGLYWTLNGRRLPPELSRVLNASTLALALANLNGSRQRSGDNLVCHARDGSILAGSCLYVGLP |
| Gene Sequence | HTAVISPQDPTLLIGSSLLATCSVHGDPPGATAEGLYWTLNGRRLPPELSRVLNASTLALALANLNGSRQRSGDNLVCHARDGSILAGSCLYVGLP |
| Gene ID - Mouse | ENSMUSG00000007888 |
| Gene ID - Rat | ENSRNOG00000020030 |
| Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
| Documents & Links for Anti CRLF1 pAb (ATL-HPA041493) | |
| Datasheet | Anti CRLF1 pAb (ATL-HPA041493) Datasheet (External Link) |
| Vendor Page | Anti CRLF1 pAb (ATL-HPA041493) at Atlas Antibodies |
| Documents & Links for Anti CRLF1 pAb (ATL-HPA041493) | |
| Datasheet | Anti CRLF1 pAb (ATL-HPA041493) Datasheet (External Link) |
| Vendor Page | Anti CRLF1 pAb (ATL-HPA041493) |
| Citations for Anti CRLF1 pAb (ATL-HPA041493) – 1 Found |
| Yu, Shi-Tong; Zhong, Qian; Chen, Ren-Hui; Han, Ping; Li, Shi-Bing; Zhang, Hua; Yuan, Li; Xia, Tian-Liang; Zeng, Mu-Sheng; Huang, Xiao-Ming. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways. Cell Death & Disease. 2018;9(3):371. PubMed |